1.50Open1.50Pre Close0 Volume25 Open Interest15.00Strike Price0.00Turnover0.00%IV0.12%PremiumDec 20, 2024Expiry Date1.48Intrinsic Value100Multiplier28DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma10.99Leverage Ratio--Theta--Rho--Eff Leverage--Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet